Impact of EGFR Inhibitor in Non―Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
CHEE KHOON LEE, BROWN, Chris, JEMELA ANNE OSORIO SANCHEZ, VU VAN VU, JOSEPH SIU KIE AU, INOUE, Akira, SIOW MING LEE, GEBSKI, Val, YANG, James Chih-Hsin, GRALLA, Richard J, HIRSH, Vera, THONGPRASERT, Sumitra, TSAI, Chun-Ming, ENG HUAT TAN, HO, James Chung-Man, DATONG CHU, ZAATAR, Adel
Published in JNCI : Journal of the National Cancer Institute (01.05.2013)
Published in JNCI : Journal of the National Cancer Institute (01.05.2013)
Get full text
Journal Article
Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study
Ho, Gwo-Fuang, Chai, Chee-Shee, Alip, Adlinda, Wahid, Mohd Ibrahim A, Abdullah, Matin Mellor, Foo, Yoke-Ching, How, Soon-Hin, Zaatar, Adel, Lam, Kai-Seng, Leong, Kin-Wah, Low, John-Seng-Hooi, Yusof, Mastura Md, Lee, Erica Chai-Yong, Toh, Yok-Yong, Liam, Chong-Kin
Published in BMC cancer (09.09.2019)
Published in BMC cancer (09.09.2019)
Get full text
Journal Article
Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma
Zaatar, Adel M, Lim, Chun Ren, Bong, Chin Wei, Lee, Michelle Mei Lin, Ooi, Jian Jiek, Suria, David, Raman, Rakesh, Chao, Samuel, Yang, Hengxuan, Neoh, Soon Bin, Liew, Choong-Chin
Published in Journal of experimental & clinical cancer research (17.09.2012)
Published in Journal of experimental & clinical cancer research (17.09.2012)
Get full text
Journal Article
Safety and Management of Toxicity Related to Aflibercept in Combination with Fluorouracil, Leucovorin and Irinotecan in Malaysian Patients with Metastatic Colorectal Cancer
Yusof, Mastura Md, Abdullah, Nik MA, Sharial, MSN Mohd, Zaatar, Adel
Published in Asian Pacific journal of cancer prevention : APJCP (2016)
Get full text
Published in Asian Pacific journal of cancer prevention : APJCP (2016)
Journal Article
Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study
Wu, Yi-Long, Kim, Joo-Hang, Park, Keunchil, Zaatar, Adel, Klingelschmitt, Gaëlle, Ng, Christina
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2012)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2012)
Get full text
Journal Article
Safety and Management of Toxicity Related to Aflibercept in Combination with Fluorouracil, Leucovorin and Irinotecan in Malaysian Patients with Metastatic Colorectal Cancer
Yusof, Mastura Md, Abdullah, Nik MA, Sharial, MSN Mohd, Zaatar, Adel
Published in Asian Pacific journal of cancer prevention : APJCP (19.04.2016)
Published in Asian Pacific journal of cancer prevention : APJCP (19.04.2016)
Get full text
Journal Article
Efficacy, tolerability, and biomarker analyses of once-every-2-weeks cetuximab plus first-line FOLFOX or FOLFIRI in patients with KRAS or all RAS wild-type metastatic colorectal cancer: the phase 2 APEC study
Cheng, A.L, Cornelio, G, Shen, L, Price, T, Yang, T.S, Chung, I.J, Dai, G.H, Lin, J.K, Sharma, A, Yeh, K.H, Ma, B, Zaatar, A, Guan, Z, Masood, N, Srimuninnimit, V, Yau, T, Gibbs, P, Wang, X, Doval, D.C, Seong-Taek, O, Shim, B.Y, Gorospe, C, Wang, H.M, Sirachainan, E, Hill, A, Suh, K.W, Beier, F, Chatterjee, S, Lim, R
Published in Clinical colorectal cancer (01.06.2017)
Published in Clinical colorectal cancer (01.06.2017)
Get full text
Journal Article
Final analysis of the phase 2 APEC study: Overall survival (OS) data and biomarker subanalyses for first-line FOLFOX or FOLFIRI with cetuximab (cet) once every 2 weeks in patients (pts) with KRAS or RAS (KRAS and NRAS, exons 2-4) wild-type (wt) metastatic colorectal cancer (mCRC)
Cheng, Ann-Lii, Cornelio, Gerardo H., Shen, Lin, Price, Timothy Jay, Yang, Tsai-Sheng, Chung, Ik-Joo, Dai, Guanghai, Lin, Jen-Kou, Sharma, Atul, Yeh, Kun-Huei, Ma, Brigette, Zaatar, Adel, Guan, Zhongzhen, Masood, Nehal, Srimuninnimit, Vichien, Yau, Thomas Cheung, Beier, Frank, Chatterjee, Sudipto, Lim, Robert S.C.
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
Efficacy and safety of every-2-weeks cetuximab combined with FOLFOX or FOLFIRI as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (mCRC): An Asia-Pacific nonrandomized phase II study (APEC)
Cheng, Ann-Lii, Cornelio, Gerardo H., Shen, Lin, Price, Timothy Jay, Yang, Tsai-Shen, Chung, Ik-Joo, Dai, Guanghai, Lin, Jen-Kou, Sharma, Atul, Yeh, Kun-Huei, Ma, Brigette, Zaatar, Adel, Guan, Zhongzhen, Masood, Nehal, Srimuninnimit, Vichien, Yau, Thomas Cheung, Sarholz, Barbara, Lim, Robert S.C.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
First-Line Cetuximab with Folfox or Folfiri Every 2 Weeks in Kras Wild-Type Metastatic Colorectal Cancer: Phase II Apec Study
Cheng, Ann-Lii, Cornelio, Gerardo, Shen, Lin, Price, Timothy, Yang, Tsai-Sheng, Chung, Ik-Joo, Dai, Guang-Hai, Lin, Jen-Kou, Sharma, Atul, Yeh, Kun-Huei, Ma, Brigette, Zaatar, Adel, Guan, Zhong-Zhen, Masood, Nehal, Srimuninnimit, Vichien, Yau, Thomas, Sarholz, Barbara, Lim, Robert
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
Safety and Management of Toxicity Related to Aflibercept in Combination with Fluorouracil, Leucovorin and Irinotecan in Malaysian Patients with Metastatic Colorectal Cancer
Yusof, Mastura Md, Abdullah, Nik Ma, Sharial, Msn Mohd, Zaatar, Adel
Published in Asian Pacific journal of cancer prevention : APJCP (2016)
Get more information
Published in Asian Pacific journal of cancer prevention : APJCP (2016)
Journal Article